{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:47:06Z","timestamp":1792075626818,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["XDB1230000"],"award-info":[{"award-number":["XDB1230000"]}],"id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014136","name":"Central Asian Center of Drug Discovery and Development of Chinese Academy of Sciences","doi-asserted-by":"publisher","award":["CAM202401"],"award-info":[{"award-number":["CAM202401"]}],"id":[{"id":"10.13039\/501100014136","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejmech.2026.118796","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:47:02Z","timestamp":1774583222000},"page":"118796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD\/MASH"],"prefix":"10.1016","volume":"310","author":[{"given":"Xingjun","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengbin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaopeng","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118796_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20420188221139650","article-title":"Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease","volume":"13","author":"Kaya","year":"2022","journal-title":"Ther. Adv. Endocrinol. Metab."},{"key":"10.1016\/j.ejmech.2026.118796_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s12072-024-10704-3","article-title":"Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver disease","volume":"18","author":"Fouad","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.ejmech.2026.118796_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.118796_bib4","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease: a systematic review","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ejmech.2026.118796_bib5","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s42255-024-00985-1","article-title":"From NAFLD to MASLD: implications of the new nomenclature for preclinical and clinical research","volume":"6","author":"Hsu","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.ejmech.2026.118796_bib6","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.3390\/nu15183970","article-title":"New insights into the pathogenesis of metabolic-associated fatty liver disease (MAFLD): gut-liver-heart crosstalk","volume":"15","author":"Yang","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.ejmech.2026.118796_bib7","first-page":"1047","article-title":"Targeting ATP-citrate lyase in hyperlipidemia and metabolic disorders, trends","volume":"23","author":"Pinkosky","year":"2017","journal-title":"Mol. Med."},{"key":"10.1016\/j.ejmech.2026.118796_bib8","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-019-1094-6","article-title":"An allosteric mechanism for potent inhibition of human ATP-citrate lyase","volume":"568","author":"Wei","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118796_bib9","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","article-title":"Acetyl coenzyme A: a central metabolite and second messenger","volume":"21","author":"Pietrocola","year":"2015","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.118796_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","article-title":"Acetyl-CoA and the regulation of metabolism: mechanisms and consequences","volume":"33","author":"Shi","year":"2015","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.118796_bib11","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1126\/science.1164097","article-title":"ATP-citrate lyase links cellular metabolism to histone acetylation","volume":"324","author":"Wellen","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.118796_bib12","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/hep.22774","article-title":"Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice","volume":"49","author":"Wang","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.ejmech.2026.118796_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1172\/JCI27300","article-title":"Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2","volume":"116","author":"Savage","year":"2006","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.118796_bib14","doi-asserted-by":"crossref","first-page":"11805","DOI":"10.1074\/jbc.RA119.008708","article-title":"Enhanced acetylation of ATP-citrate lyase promotes the progression of nonalcoholic fatty liver disease","volume":"294","author":"Guo","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib15","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejmech.2026.118796_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-10930-w","article-title":"Human hepatic gene expression signature of non-alcoholic fatty liver disease progression, a meta-analysis","volume":"7","author":"Ryaboshapkina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.118796_bib17","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.apsb.2022.06.011","article-title":"Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia","volume":"13","author":"Xie","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejmech.2026.118796_bib18","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.6023\/cjoc202405036","article-title":"Discovery of alkyl conjugated diene diacids as novel ACLY inhibitors","volume":"44","author":"Cheng","year":"2024","journal-title":"Chin. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib19","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1021\/acs.jcim.2c00345","article-title":"Discovery of a novel macrocyclic ATP citrate lyase inhibitor","volume":"62","author":"Zang","year":"2022","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2026.118796_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2025.117684","article-title":"Design, synthesis, and biological evaluation of novel macrocyclic derivatives as potent ATP-citrate lyase inhibitors","volume":"292","author":"Zang","year":"2025","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106933","article-title":"Recent advance of ATP citrate lyase inhibitors for the treatment of cancer and related diseases","volume":"142","author":"Liang","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2024.105956","article-title":"Discovery and characterization of novel ATP citrate lyase inhibitors from (rupr. & maxim.) harms","volume":"175","author":"Wang","year":"2024","journal-title":"Fitoterapia"},{"key":"10.1016\/j.ejmech.2026.118796_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110199","article-title":"Discovery and characterization of novel ATP citrate lyase inhibitors from natural products by a luminescence-based assay","volume":"367","author":"Wang","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2026.118796_bib24","doi-asserted-by":"crossref","first-page":"885","DOI":"10.4155\/fmc.14.50","article-title":"Conformational restriction: an effective tactic in 'follow-on'-based drug discovery","volume":"6","author":"Fang","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib25","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1002\/pro.3708","article-title":"Identification of the active site residues in ATP-citrate lyase's carboxy-terminal portion","volume":"28","author":"Nguyen","year":"2019","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2026.118796_bib26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nature15375","article-title":"Crystal structure of the 500-kDa yeast acetyl-CoA carboxylase holoenzyme dimer","volume":"526","author":"Wei","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118796_bib27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmech.2017.02.007","article-title":"Analogues of xanthones- -Chalcones and bis-chalcones as \u03b1-glucosidase inhibitors and anti-diabetes candidates","volume":"130","author":"Cai","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106320","article-title":"Chalcone derivatives as xanthine oxidase inhibitors: synthesis, binding mode investigation, biological evaluation, and ADMET prediction","volume":"131","author":"Yang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","article-title":"Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments","volume":"27","author":"Sastry","year":"2013","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2026.118796_bib30","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","article-title":"OPLS4: improving force field accuracy on challenging regimes of chemical space","volume":"17","author":"Lu","year":"2021","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.ejmech.2026.118796_bib31","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118796_bib32","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"Jacobson","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.ejmech.2026.118796_bib33","series-title":"SC '06: Proceedings of the 2006 ACM\/IEEE Conference on Supercomputing","first-page":"43","article-title":"Scalable algorithms for molecular dynamics simulations on commodity clusters","author":"Bowers","year":"2006"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T15:47:01Z","timestamp":1776181621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426002412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":33,"alternative-id":["S0223523426002412"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118796","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of novel ATP-citrate lyase inhibitors and their effects on MAFLD\/MASH","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118796","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118796"}}